Advice to Patients
- Importance of immediately informing clinician of occurrence of tightness, pain, pressure, or heaviness in chest, throat, jaw, or neck; sudden or severe abdominal pain; shortness of breath or wheezing; heart throbbing; facial swelling (e.g., eyelids, face, lips); tongue, mouth or throat swelling; rash or hives and of not taking zolmitriptan again until evaluated by a clinician. Importance of informing clinician of any other symptoms not understood by patient.
- Importance of adhering to prescribed directions for use. Importance of patient reading manufacturer's patient information before initial use and each time prescription is refilled.
- For patients taking zolmitriptan orally disintegrating tablets, importance of not removing tablet from blister package until just before administering dose; importance of peeling blister open and placing tablet on tongue to dissolve and be swallowed with saliva.
- Importance of informing patients with phenylketonuria that orally disintegrating tablets contain aspartame.
- Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs, dietary supplements, and herbal supplements, as well as any concomitant illnesses (e.g., cardiovascular disease).
- Importance of informing patients of risk of serotonin syndrome with concurrent use of zolmitriptan and an SSRI or SNRI. Importance of seeking immediate medical attention if symptoms of serotonin syndrome develop.
- Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.
- Importance of informing patients of other important precautionary information. (See Cautions.)
Preparations
Zolmitriptan
| Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
| Nasal | Solution | 5 mg/0.1 mL |
Zomig® Nasal Spray | AstraZeneca |
| Oral | Tablets, film-coated | 2.5 mg |
Zomig® | AstraZeneca |
| | 5 mg |
Zomig® | AstraZeneca |
| Tablets, orally disintegrating | 2.5 mg |
Zomig-ZMT® (with aspartame) | AstraZeneca |
| | 5 mg |
Zomig-ZMT® (with aspartame) | AstraZeneca |
Comparative Pricing
This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.
| Zomig 2.5MG Tablets | ASTRAZENECA | 6/$119.98 or 18/$319.98 |
| Zomig 5MG Solution | ASTRAZENECA | 6/$174.09 or 18/$503.22 |
| Zomig 5MG Tablets | ASTRAZENECA | 3/$67.99 or 9/$185.97 |
| Zomig ZMT 2.5MG TBDP | ASTRAZENECA | 6/$105.99 or 18/$309.99 |
| Zomig ZMT 5MG TBDP | ASTRAZENECA | 3/$69.3 or 9/$184.79 |
AHFS Drug Information. © Copyright, 1959-2008, Selected Revisions August 2007. American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland 20814.
Remember, keep this and all other medicines out of the reach of children,
never share your medicines with others, and use this medication only for the indication prescribed.